Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: Clinical features, underlying diseases and prognosis

AIDS

Volumn 24, Issue 9, 2010, Pages 1299-1306

  Fardet, Laurence ^a,b   Lambotte, Olivier ^c   Meynard, Jean Luc ^d   Kamouh, Wassim ^c   Galicier, Lionel ^e   Marzac, Christophe ^f   De Labarthe, Adrienne ^f   Cabane, Jean ^a   Lebbe, Céleste ^b   Coppo, Paul ^g   Molina, Jean Michel ^d   Martinez, Valérie ^d  

^a HÔPITAL SAINT ANTOINE   (France)

^b Service de Dermatologie   (United States)

^c HÔpital Saint Antoine AP HP   (France)

^d Service des Maladies Infectieuses   (France)

^e Hop S Louis 1 Ave Claude V   (France)

^f Service d'Hématologie Biologique   (France)

^g Serv d'Hématologie Clinique   (France)

Author keywords

AIDS; Haemophagocytic syndrome; Haemophagocytosis; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; VIRUS RNA;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE DURATION; FEMALE; FRANCE; HEMOPHAGOCYTIC SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOLID TUMOR; SPLENOMEGALY; TUBERCULOSIS; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77952895495     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328339e55b     Document Type: Article

References (41)

1. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection-and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12:435-444.
2. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemopha-gocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005; 135:299-314.
3. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988; 67:369-388.
4. Tiab M, Mechinaud F, Harousseau JL. Haemophagocytic syndrome associated with infections. Baillieres Best Pract Res Clin Haematol 2000; 13:163-178.
5. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6:601-608.
6. Tiab M, Mechinaud F, Hamidou M, Gaillard F, Raffi F, Harousseau JL. Hemophagocytic syndromes. A series of 23 cases. Ann Med Interne (Paris) 1996; 147:138-144.
7. Grateau G, Bachmeyer C, Blanche P, Jouanne M, Tulliez M, Galland C, et al. Hemophagocytic syndrome in patients infected with the human immunodeficiency virus: nine cases and a review. J Infect 1997; 34:219-225.
8. Sailler L, Duchayne E, Marchou B, Brousset P, Pris J, Massip P, et al. Etiological aspects of reactive hemophagocytoses: retrospective study in 99 patients. Rev Med Interne 1997; 18:855-864.
9. Wong KF, Chan JK. Reactive hemophagocytic syndrome: a clinicopathologic study of 40 patients in an Oriental population. Am J Med 1992; 93:177-180.
10. Doyle T, Bhagani S, Cwynarski K. Haemophagocytic syndrome and HIV. Curr Opin Infect Dis 2009; 22:1-6.
11. Bourquelot P, Oksenhendler E, Wolff M, Fegueux S, Piketty C, D'Agay MF, et al. Hemophagocytic syndrome in HIV infection. Presse Med 1993; 22:1217-1220.
12. Niedt GW, Schinella RA. Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. Arch Pathol Lab Med 1985; 109:727-734.
13. www.who.int/classifications/apps/icd/icd10online/[Accessed 09 April 2010]
14. Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004; 50:157-174.
15. Chandra P, Chaudhery SA, Rosner F, Kagen M. Transient histiocytosis with striking phagocytosis of platelets, leukocytes, and erythrocytes. Arch Intern Med 1975; 135:989-991.
16. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44:993-1002.
17. Fardet L, Blum L, Kerob D, Agbalika F, Galicier L, Dupuy A, et al. Human herpesvirus 8-associated hemophagocytic lym-phohistiocytosis in human immunodeficiency virus-infected patients. Clin Infect Dis 2003; 37:285-291.
18. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al., for the HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645-1654.
19. Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, et al., Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group; Mortavic Study Group. Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Clin Infect Dis 2009; 48:633-639.
20. Bhaskaran K, HamoudaO, Sannes M,Boufassa F,JohnsonAM, Lambert PC, et al., CASCADE Collaboration. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008; 300: 51-59.
21. Fardet L, Coppo P, Kettaneh A, Dehoux M, Cabane J, Lambotte O. Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis Rheum 2008; 58:1521-1527.
22. Guo X, Li Q, Zhou CY. Retrospective analysis of 41 childhood hemophagocytic syndrome. Zhonghua XueYeXueZaZhi 2007; 28:449-453.
23. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003; 49:633-639.
24. Clifford GM, Rickenbach M, Lise M, Dal Maso L, Battegay M, Bohlius J, et al., Swiss HIV Cohort Study. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood 2009; 113:5737-5742.
25. Bulletin Epidemiologique Hebdomadaire. [Special issue-HIV and AIDS infection in France and in Europe.] 8 46-47 www.invs.sante.fr/beh/2007/46-47/ beh-46-47.pdf [Accessed 09 April 2010].
26. Ménasché G, Feldmann J, Fischer A, de Saint Basile G. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 2005; 203:165-179.
27. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemo-phagocytic lymphohistiocytosis. Science 1999; 286:1957-1959.
28. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohis-tiocytosis (FHL3). Cell 2003; 115:461-473.
29. Feldmann J, Le Deist F, Ouachee-Chardin M, Certain S, Alexander S, Quartier P, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemo-phagocytic lymphohistiocytosis. Br J Haematol 2002; 117:965-972.
30. Khalil SH, Nounou RM, Frayha H, Halim MA, Ellis M, Black FT. Bone marrow morphologic findings in patients with human immunodeficiency virus (HIV) infection. Ann Saudi Med 1996; 16:16-19.
31. Marche C, Tabbara W, Michon C, Clair B, Bricaire F, Matthies-sen L. Bone marrow findings in HIV infection: a pathological study. Prog AIDS Pathol 1990; 2:51-60.
32. De Lavaissière M, Manceron V, Bourée P, Garçon L, Bisaro F, Delfraissy JF, et al. Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection. J Infect 2009; 58:245-247.
33. Cuttelod M, Pascual A, Baur Chaubert AS, Cometta A, Osih R, Duchosal MA, et al. Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome? AIDS 2008; 22:549-551.
34. Huang DB, Wu JJ, Hamill RJ. Reactive hemophagocytosis associated with the initiation of highly active antiretroviral therapy (HAART) in a patient with AIDS. Scand J Infect Dis 2004; 36:516-519
35. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune recon-stitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002; 81:213-227.
36. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, Gicquel B, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006; 20:F1-7.
37. Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005; 106:3483-3489.
38. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89:4100-4103.
39. Jordan MB, HildemanD,KapplerJ,MarrackP.Ananimal model of hemophagocytic lymphohistiocytosis (HLH): CD8R T cells and interferon gamma are essential for the disorder. Blood 2004; 104:735-743.
40. Chuang HC, Lay JD, Hsieh WC, Wang HC, ChangY,Chuang SE, Su IJ. Epstein-Barr virus LMP1inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenis of hemophagocytic syndrome. Blood 2005; 106:3090-3096.
41. Holzelova E, Vonarbourg C, Stolzenberg MC, Arkwright PD, Selz F, Prieur AM, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004; 351:1409-1418.